Callan Capital, LLC Gossamer Bio, Inc. Transaction History
Callan Capital, LLC
- $1.36 Billion
- Q4 2024
A detailed history of Callan Capital, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Callan Capital, LLC holds 30,000 shares of GOSS stock, worth $39,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$39,300% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
153MCall Options Held
793KPut Options Held
528K-
Octagon Capital Advisors LP New York, NY18.4MShares$24 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$23.7 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$13.1 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$11.5 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$10.6 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $123M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...